Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2.
作者信息
Cauchi M, Robertson N P
机构信息
Department of Neurology, Division of Psychological Medicine and Clinical Neuroscience, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
出版信息
J Neurol. 2021 May;268(5):2002-2004. doi: 10.1007/s00415-021-10513-w. Epub 2021 Mar 15.
Abstract
摘要
相似文献
1
Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2.神经病学与疫苗接种：COVID-19/SARS-CoV-2背景下的考量
J Neurol. 2021 May;268(5):2002-2004. doi: 10.1007/s00415-021-10513-w. Epub 2021 Mar 15.
2
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.呼吁公平获取 COVID-19 诊断、疫苗和治疗方法：欧洲神经病学学会的 NeuroCOVID-19 工作组。
Eur J Neurol. 2021 Nov;28(11):3849-3855. doi: 10.1111/ene.14741. Epub 2021 Feb 5.
3
Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort.血液肿瘤患者 SARS-CoV-2 感染和疫苗接种的及时进程：真实队列分析。
ESMO Open. 2023 Jun;8(3):101559. doi: 10.1016/j.esmoop.2023.101559. Epub 2023 Apr 25.
4
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.在接受抗 CD20 治疗和鞘氨醇-1-磷酸受体调节剂治疗的 MS 患者中，序贯接种 SARS-CoV-2 疫苗后的纵向适应性免疫反应。
Mult Scler Relat Disord. 2023 Feb;70:104484. doi: 10.1016/j.msard.2022.104484. Epub 2022 Dec 28.
5
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations.抗 CD20 治疗的多发性硬化症患者在接种三到四剂 COVID-19 疫苗后，体液免疫反应仍然存在数量上的缺陷，但在质量上有所改善。
Mult Scler. 2023 Jun;29(7):884-888. doi: 10.1177/13524585231161253. Epub 2023 Mar 28.
6
Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.接种新型冠状病毒2疫苗后功能性神经障碍风险增加。
Eur J Neurol. 2024 Apr;31(4):e16191. doi: 10.1111/ene.16191. Epub 2024 Jan 2.
7
The COVID-19 pandemic, an environmental neurology perspective.从环境神经科学角度看 COVID-19 大流行
Rev Neurol (Paris). 2022 Jun;178(6):499-511. doi: 10.1016/j.neurol.2022.02.455. Epub 2022 Mar 22.
8
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system.巴西神经病学学会神经免疫学科学部（DCNI/ABN）以及巴西多发性硬化症和神经免疫疾病治疗与研究委员会（BCTRIMS）关于一般疫苗接种，特别是针对中枢神经系统脱髓鞘疾病患者接种新型冠状病毒2（SARS-CoV-2）疫苗的建议。
Arq Neuropsiquiatr. 2021 Nov;79(11):1049-1061. doi: 10.1590/0004-282X-ANP-2021-0162.
9
Current Perspective of COVID-19 on Neurology: A Mechanistic Insight.新型冠状病毒肺炎对神经科影响的当前观点：机制见解。
Comb Chem High Throughput Screen. 2022;25(5):763-767. doi: 10.2174/1386207324666210805121828.
10
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study.患者报告的 COVID-19 疫苗与对照疫苗的不良反应和安全性：一项比较观察性队列研究。
BMC Med. 2023 Sep 19;21(1):358. doi: 10.1186/s12916-023-03064-6.
Zotero 插件